Management strategies for recurrent vasovagal syncope

Area of Science:

• Cardiology
• Neurology

Background:

• Vasovagal syncope (VVS) is the most frequent cause of recurrent fainting, impacting both young and elderly populations.
• Despite a high lifetime incidence of syncope (35%), diagnosis and treatment remain challenging.
• Older patients often exhibit atypical VVS presentations, necessitating comprehensive diagnostic evaluations.

Purpose of the Study:

• To review the diagnostic approaches and therapeutic strategies for vasovagal syncope.
• To highlight the importance of identifying a distinct VVS subtype characterized by low supine systolic blood pressure.
• To discuss the limited but available treatment options for recurrent VVS.

Main Methods:

• Review of existing literature on vasovagal syncope diagnosis and management.
• Emphasis on detailed patient history for diagnosis, particularly in younger individuals.
• Identification of patient subgroups, such as those with low supine systolic blood pressure.

Main Results:

• A detailed history is often sufficient for diagnosing VVS in younger patients.
• Low supine systolic blood pressure identifies a distinct VVS subtype potentially responsive to tailored therapy.
• Limited randomized trials exist, but patient education, trigger avoidance, hydration, and physical counter-pressure maneuvers form the cornerstone of VVS management.

Conclusions:

• Tailored therapeutic approaches may benefit specific VVS patient subtypes.
• Pharmacological interventions like fludrocortisone, midodrine, or SSRIs are reserved for select cases.
• Permanent cardiac pacing is generally not recommended for VVS based on current evidence.